应重视数字医疗在帕金森病患者管理中的作用

doi:10.3969/j.issn.1672-6731.2022.03.001

中国现代神经疾病杂志 ›› 2022, Vol. 22 ›› Issue (3): 127-130. doi: 10.3969/j.issn.1672-6731.2022.03.001

2 应重视数字医疗在帕金森病患者管理中的作用

陈彪, 张齐皓

100053 北京, 首都医科大学宣武医院神经内科

收稿日期:2022-03-19 出版日期:2022-03-25 发布日期:2022-03-31
通讯作者: 陈彪,Email:pbchan@hotmail.com
基金资助:
国家重点研发计划重点专项（项目编号：2021YFC2501200）

Importance of digital health in patient management of Parkinson's disease

CHAN Piu, ZHANG Qi-hao

Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China

Received:2022-03-19 Online:2022-03-25 Published:2022-03-31
Supported by:
This study was supported by the National Key Research and Develoment Program of China (No. 2021YFC2501200).

摘要/Abstract

摘要： 随着技术创新的不断迭代，医疗健康迎来数字医疗发展的新阶段。本文阐述数字医疗的内涵与应用，探讨数字医疗在帕金森病患者管理中的进展、优势与不足，以期引导数字医疗为完善帕金森病患者全程管理体系搭桥铺路，为提高患者生活质量、全面实现健康中国奠定基础。

关键词: 帕金森病, 卫生保健提供, 数字医疗(非MeSH词)

Abstract: With the continuous iteration of technological innovation, the medical and health industry ushered in a new stage of digital health development. This article expounds the connotation and application of digital health, and discusses the development, advantages and disadvantages of digital health in the management of patients with Parkinson's disease (PD), so as to utilize digital health to pave the way for improving the whole-disease-cycle management of patients with PD, and to lay the foundation for improving their health and well-being and realizing Healthy China in an all-round way.

Key words: Parkinson disease, Delivery of health care, Digital health (not in MeSH)

陈彪, 张齐皓. 应重视数字医疗在帕金森病患者管理中的作用[J]. 中国现代神经疾病杂志, 2022, 22(3): 127-130.

CHAN Piu, ZHANG Qi-hao. Importance of digital health in patient management of Parkinson's disease[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2022, 22(3): 127-130.

https://journal11.magtechjournal.com/cjcnn/CN/Y2022/V22/I3/127

参考文献

[1] Global strategy on digital health 2020-2025[DB/OL]. Geneva:World Health Organization, 2021[2022-03-12]. https://apps.who.int/iris/bitstream/handle/10665/344249/9789240020924-eng.pdf
[2] Digital Health Center of Excellence[DB/OL]. Washington:U.S.S. Food & Drug Administration, 2022[2022-03-12]. https://www.fda.gov/medical-devices/digital-health-center-excellence
[3] Fatehi F, Samadbeik M, Kazemi A. What is digital health:review of definitions[J]? Stud Health Technol Inform, 2020, 275:67-71.
[4] Xue P, Bai AY, Jiang Y, Qiao YL. WHO global strategy on digital health and its implications to China[J]. Zhonghua Yu Fang Yi Xue Za Zhi, 2022, 56:218-221.[薛鹏, 白安颖, 江宇,乔友林. WHO数字健康全球战略及对中国的启示[J]. 中华预防医学杂志, 2022, 56:218-221.]
[5] Liu SY, Chan P. Epidemiology of Parkinson's disease[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2016, 16:98-101.[刘疏影, 陈彪. 帕金森病流行现状[J]. 中国现代神经疾病杂志, 2016, 16:98-101.]
[6] Parkinson's Disease and Movement Disorders Group, Neurologist Branch, Chinese Medial Association; Committee of Parkinson's Disease and Dyskinesia, Neurologist Branch, Chinese Medical Doctor Association. Chinese expert consensus on research criteria for prodromal Parkinson's disease[J]. Zhonghua Lao Nian Yi Xue Za Zhi, 2019, 38:825-831.[中华医学会神经病学分会帕金森病及运动障碍学组, 中国医师协会神经内科医师分会帕金森病及运动障碍病专业委员会. 帕金森病前驱期诊断研究标准中国专家共识[J]. 中华老年医学杂志, 2019, 38:825-831.]
[7] Hawkes CH, Del Tredici K, Braak H. A timeline for Parkinson's disease[J]. Parkinsonism Relat Disord, 2010, 16:79-84.
[8] Riggare S, Stamford J, Hägglund M. A long way to go:patient perspectives on digital health for Parkinson's disease[J]. J Parkinsons Dis, 2021, 11(s1):S5-10.
[9] Mirelman A, Dorsey ER, Brundin P, Bloem BR. Using technology to reshape clinical care and research in Parkinson's disease[J]. J Parkinsons Dis, 2021, 11(s1):S1-3.
[10] Klucken J, Krüger R, Schmidt P, Bloem BR. Management of Parkinson's disease 20 years from now:towards digital health pathways[J]. J Parkinsons Dis, 2018, 8(s1):S85-94.
[11] Healthy China Action Promotion Committee. Healthy China Action (2019-2030):overall requirements, major actions and key indicators[J]. Zhongguo Xun Huan Za Zhi, 2019, 34:846-858.[健康中国行动推进委员会. 健康中国行动(2019-2030年):总体要求、重大行动及主要指标[J]. 中国循环杂志, 2019, 34:846-858.]
[12] Dorsey ER, Okun MS, Bloem BR. Care, convenience, comfort, confidentiality, and contagion:the 5 C's that will shape the future of telemedicine[J]. J Parkinsons Dis, 2020, 10:893-897.
[13] Hanein Y, Mirelman A. The home-based sleep laboratory[J]. J Parkinsons Dis, 2021, 11(s1):S71-76.
[14] Sacks L, Kunkoski E. Digital health technology to measure drug efficacy in clinical trials for Parkinson's disease:a regulatory perspective[J]. J Parkinsons Dis, 2021, 11(s1):S111-115.
[15] Del Din S, Kirk C, Yarnall AJ, Rochester L, Hausdorff JM. Body-worn sensors for remote monitoring of Parkinson's disease motor symptoms:vision, state of the art, and challenges ahead[J]. J Parkinsons Dis, 2021, 11(s1):S35-47.
[16] Simonet C, Noyce AJ. Domotics, smart homes, and Parkinson's disease[J]. J Parkinsons Dis, 2021, 11(s1):S55-63.
[17] Number of smartphone subscriptions worldwide from 2016 to 2027[DB/OL]. Telecommunications, 2022[2022-03-12]. https://www.www.statista.com/statistics/330695/number-of-smartphone-users-worldwide/
[18] Little MA. Smartphones for remote symptom monitoring of Parkinson's disease[J]. J Parkinsons Dis, 2021, 11(s1):S49-53.
[19] Shalash A, Spindler M, Cubo E. Global perspective on telemedicine for Parkinson's disease[J]. J Parkinsons Dis, 2021, 11(s1):S11-18.
[20] Ellis TD, Earhart GM. Digital therapeutics in Parkinson's disease:practical applications and future potential[J]. J Parkinsons Dis, 2021, 11(s1):S95-101.
[21] Christie RH, Abbas A, Koesmahargyo V. Technology for measuring and monitoring treatment compliance remotely[J]. J Parkinsons Dis, 2021, 11(s1):S77-81.
[22] Theodoros D. Telerehabilitation for communication and swallowing disorders in Parkinson's disease[J]. J Parkinsons Dis, 2021, 11(s1):S65-70.
[23] Dobkin RD, Interian A, Durland JL, Gara MA, Menza MA. Personalized telemedicine for depression in Parkinson's disease:a pilot trial[J]. J Geriatr Psychiatry Neurol, 2018, 31:171-176.
[24] Cui L, Hou NN, Wu HM, Zuo X, Lian YZ, Zhang CN, Wang ZF, Zhang X, Zhu JH. Prevalence of Alzheimer's disease and Parkinson's disease in China:an updated systematical analysis[J]. Front Aging Neurosci, 2020, 12:603854.
[25] Zhou XF, Chen L. Digital health care in China and access for older people[J]. Lancet Public Health, 2021, 6:e873-874.

选择文件类型/文献管理软件名称

选择包含的内容

2 应重视数字医疗在帕金森病患者管理中的作用

Importance of digital health in patient management of Parkinson's disease

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张峰, 孟凡刚. 帕金森病自主神经功能障碍丘脑底核脑深部电刺激术治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(7): 510-515.
[2]	常博文, 梅加明, 熊赤, 陈鹏, 蒋曼丽, 牛朝诗. 帕金森病丘脑底核脑深部电刺激术抑郁改善率相关脑功能连接分析[J]. 中国现代神经疾病杂志, 2024, 24(7): 532-539.
[3]	程轶峰, 尹绍雅, 崔德秋, 王春娟, 赵光锐, 冯珂珂. 变频刺激模式脑深部电刺激术治疗帕金森病轴性症状的长期随访研究[J]. 中国现代神经疾病杂志, 2024, 24(7): 547-554.
[4]	何平, 徐欣, 凌至培. 早发型帕金森病丘脑底核脑深部电刺激术后长期随访一例[J]. 中国现代神经疾病杂志, 2024, 24(7): 555-558.
[5]	涂敏, 杨双凤, 谭裕玲, 王晓明. 帕金森病视网膜改变与疾病严重程度的相关分析[J]. 中国现代神经疾病杂志, 2024, 24(7): 559-566.
[6]	史若琳, 高秀洁, 崔家宁, 邵妍, 谢璐霜, 刘毅. 5-羟色胺与帕金森病非运动症状研究进展[J]. 中国现代神经疾病杂志, 2024, 24(6): 497-501.
[7]	姜雨菡, 周梦溪, 陈伟. 前庭诱发肌源性电位在帕金森病诊断中的应用[J]. 中国现代神经疾病杂志, 2024, 24(3): 127-130.
[8]	徐滢, 桂雅星. 脂质代谢异常对帕金森病进程的影响及临床意义[J]. 中国现代神经疾病杂志, 2024, 24(3): 131-138.
[9]	叶诗怡, 张克忠. 帕金森病构音障碍[J]. 中国现代神经疾病杂志, 2024, 24(3): 139-145.
[10]	毕怡青, 吴凤娟, 朱玉港, 刘艺鸣. 帕金森病躯干前屈症发病机制及治疗[J]. 中国现代神经疾病杂志, 2024, 24(3): 146-150.
[11]	赵卿, 卜时嬴, 靳令经. 机器人辅助步行训练改善帕金森病步态障碍研究进展[J]. 中国现代神经疾病杂志, 2024, 24(3): 151-157.
[12]	刘再朝, 焦悦, 李娟, 陈先文. 表面肌电图对评估帕金森病肌强直的作用[J]. 中国现代神经疾病杂志, 2024, 24(3): 158-163.
[13]	龚梦茜, 孙迎迎, 徐传英, 张伟, 祖洁, 崔桂云. 血清8-羟基脱氧鸟苷和丙二醛与帕金森病认知功能障碍的相关分析[J]. 中国现代神经疾病杂志, 2024, 24(3): 164-170.
[14]	姬莉, 杨宁, 刘卫国, 牛程麟. 老年帕金森病患者自主神经功能与认知功能的相关分析[J]. 中国现代神经疾病杂志, 2024, 24(3): 171-176.
[15]	刘晨, 干静, 张煜, 刘振国. LRRK2基因R1067Q和GBA基因R202Q双变异致早发型帕金森病一例[J]. 中国现代神经疾病杂志, 2024, 24(3): 177-181.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 应重视数字医疗在帕金森病患者管理中的作用

Importance of digital health in patient management of Parkinson's disease

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价